Explore opportunities with Novartis below.

Montreal, November 15, 2024 – Novartis Pharmaceuticals Canada Inc. (Novartis Canada) is extremely disappointed that negotiations for PLUVICTO™ (lutetium (177Lu) vipivotide tetraxetan injection), a ...

At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

The main objective of the CWP is to improve the quality of care for patients and support the early identification, review, and medical optimisation of patients with atherosclerotic cardiovascular ...

The main objective of the CWP is to improve the quality of care for patients and support the early identification, review, and medical optimisation of patients with atherosclerotic cardiovascular ...

Media inquiry: please contact our Communications & Engagement team at [email protected] or the Media Line at 514-633-7873 Medical questions or prescription drugs:, please contact our medical ...

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...

Zum 15. Mal: Novartis prämiert vielversprechende Forschungsprojekte in der Multiplen Sklerose (MS) mit insgesamt 100.000 Euro Dr. Sofia Meyer zu Reckendorf, Ulm, setzt sich in der Kategorie ,Präklinik ...